A Phase 1 Study of the DNA-PK Inhibitor Peposertib in Combination With Radiation Therapy With or Without Cisplatin in Patients With Advanced Head and Neck Tumors
Michael A. Samuels(Banner MD Anderson Cancer Center), Esther G.C. Troost(Heidelberg University)
International Journal of Radiation Oncology*Biology*Physics
September 24, 2023
Cited by 62
Related Papers
Update of the EPTN atlas for CT- and MR-based contouring in Neuro-Oncology
|Radiotherapy and Oncology|2021|69